The Nifty Pharma index closed 0.85 per cent up at 12705.4.

“Hiring new trainees, training them, putting them on the job reduces the impact of attrition and that is being seen. However, it is still at the higher end. A good sign is this time it seems to be stabilising or going down but we need to still work on to see that attrition comes to a normal level. Otherwise, the impact of attrition on wages and margins will remain,” says Ashank Desai

With the launch of AIF, we move a step closer to realizing our dream of offering investment solutions to all categories of investors, right from Gulaq portfolios (Brain Child of Estee Advisors) for retail investors to PMS & AIFs for large, sophisticated investors. The key differentiator in all these products is the quant drive approach in which we take great pride in being the market leaders," he said.

For the quarter ended June 30, 2022, the company reported consolidated net sales of Rs 71,934.66 crore, up 8.32 per cent from the year-ago quarter's net sales of Rs 66,406.45 crore. The company reported a net loss of Rs 4,987 crore for the latest quarter.

“The actual impact of EVs on the financials will be seen probably in FY26. Yes, we have to look at the future and analyse the company and that is the reason why we are trying to identify the winners but at this stage, I will still go with Mahindra & Mahindra.”

The Nifty Realty index closed 0.67 per cent down at 414.25.

ETMarkets found 25 companies in the BSE 500 list whose annual profit numbers are decreasing over the last two financial years. We further drill our research for the price performance and we come across seven stocks that have already fallen over 20 per cent in FY23 so far.

The yuan has exceeded expectations it might fall to 7 to the dollar after the Federal Reserve started aggressive rate hikes to cool inflation that is at a four-decade high. The Fed has raised rates five times this year and says more increases are likely.